XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.19.1

Impairment, restructuring and other charges | 9 Months Ended
--- | ---
Mar. 31, 2019
Impairment, restructuring and other charges |
Impairment, restructuring and other charges | 5. Impairment, restructuring and other charges Impairment During the three and nine months ended March 31, 2019, there were no impairment charges. During the nine months ended March 31, 2018, we (i) abandoned a product line in our Security division that became redundant as a result of the ETD acquisition, (ii) abandoned a non-core product line in our Healthcare division, and (iii) abandoned certain trademarks in our Optoelectronics and Manufacturing division that were no longer used. As a result, $7.1 million of assets, including intangible and fixed assets, were written off as we determined that these assets had no value and were permanently impaired. Restructuring and Other Charges We endeavor to align our global capacity and infrastructure with demand by our customers and also to fully integrate acquisitions, and thereby improve operational efficiency. The following table summarizes impairment, restructuring and other charges for the periods set forth below (in thousands):
|  | Three Months Ended March 31, 2018
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Impairment charges |  | $ | 91 |  | $ | 3,946 |  | $ | — |  | $ | — |  | $ | 4,037
Acquisition-related costs |  |  | — |  |  | — |  |  | — |  |  | 77 |  |  | 77
Employee termination costs |  |  | 18 |  |  | 3 |  |  | 269 |  |  | — |  |  | 290
Facility closures/consolidation |  |  | 117 |  |  | (8) |  |  | — |  |  | — |  |  | 109
Legal and accrued settlement costs, net |  |  | — |  |  | 5,766 |  |  | — |  |  | 3,783 |  |  | 9,549
Total expensed |  | $ | 226 |  | $ | 9,707 |  | $ | 269 |  | $ | 3,860 |  | $ | 14,062
|  | Three Months Ended March 31, 2019
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Acquisition-related costs |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Employee termination costs |  |  | — |  |  | — |  |  | — |  |  | — |  |  | —
Facility closures/consolidation |  |  | — |  |  | — |  |  | — |  |  | — |  |  | —
Legal and accrued settlement costs, net |  |  | — |  |  | — |  |  | — |  |  | (1,777) |  |  | (1,777)
Total expensed |  | $ | — |  | $ | — |  | $ | — |  | $ | (1,777) |  | $ | (1,777)
|  | Nine Months Ended March 31, 2018
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Impairment charges |  | $ | 1,581 |  | $ | 4,525 |  | $ | 1,075 |  | $ | — |  | $ | 7,181
Acquisition-related costs |  |  | — |  |  | — |  |  | — |  |  | 1,258 |  |  | 1,258
Employee termination costs |  |  | 348 |  |  | 3 |  |  | 415 |  |  | — |  |  | 766
Facility closures/consolidation |  |  | 198 |  |  | 235 |  |  | — |  |  | — |  |  | 433
Legal and accrued settlement costs, net |  |  | — |  |  | 9,966 |  |  | — |  |  | 3,885 |  |  | 13,851
Total expensed |  | $ | 2,127 |  | $ | 14,729 |  | $ | 1,490 |  | $ | 5,143 |  | $ | 23,489
|  | Nine Months Ended March 31, 2019
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Acquisition-related costs |  | $ | — |  | $ | — |  | $ | 287 |  | $ | — |  | $ | 287
Employee termination costs |  |  | — |  |  | 1,442 |  |  | 133 |  |  | — |  |  | 1,575
Facility closures/consolidation |  |  | — |  |  | 2,084 |  |  | — |  |  | — |  |  | 2,084
Legal and accrued settlement costs, net |  |  | — |  |  | — |  |  | — |  |  | (2,792) |  |  | (2,792)
Total expensed |  | $ | — |  | $ | 3,526 |  | $ | 420 |  | $ | (2,792) |  | $ | 1,154
The changes in the accrued liability for restructuring and other charges for the nine month period ended March 31, 2019 were as follows (in thousands):
|  |  |  |  |  |  |  | Facility |  |  |  |  |
|  |  |  | Employee |  | Closure/ |  | Legal |  |  |
|  | Acquisition- |  | Termination |  | Consolidation |  | and Settlement |  |  |
|  | related Costs |  | Costs |  | Cost |  | Charges |  | Total
Balance as of June 30, 2018 |  | $ | — |  | $ | 837 |  | $ | 399 |  | $ | 14,065 |  | $ | 15,301
Restructuring and other charges,net |  |  | 287 |  |  | 1,575 |  |  | 2,084 |  |  | (2,792) |  |  | 1,154
Payments and other adjustments |  |  | (287) |  |  | (2,147) |  |  | (2,163) |  |  | (1,195) |  |  | (5,792)
Balance as of March 31, 2019 |  | $ | — |  | $ | 265 |  | $ | 320 |  | $ | 10,078 |  | $ | 10,663

X
- Definition The entire disclosure for impairment, restructuring and related activities. Description of impairment costs and restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References No definition available. + Details
Name: | osis_ImpairmentRestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | osis_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration